Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Massachusetts General Hospital |
---|---|
Information provided by: | Massachusetts General Hospital |
ClinicalTrials.gov Identifier: | NCT00786162 |
The specific aim of the study is to assess the impact of an Internet-enabled, automated, self-management program on blood pressure control of employees of a large local company.
Condition | Intervention |
---|---|
Blood Pressure |
Other: Internet-enabled automated self-management program Other: BP cuff at workplace |
Study Type: | Interventional |
Study Design: | Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Blood Pressure Self Management for Hypertension & Prehypertension Using an Internet Enabled, Automated Self Management Program |
Estimated Enrollment: | 402 |
Study Start Date: | April 2007 |
Estimated Study Completion Date: | December 2008 |
Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Intervention: Experimental
Internet-based hypertension self-management platform
|
Other: Internet-enabled automated self-management program
An internet platform to display blood pressure readings and provide subjects with automated messages and educational information about hypertension management.
|
Control: Active Comparator
Installation of BP cuff for communal use at the worksite
|
Other: BP cuff at workplace
Provided BP cuff for communal use at the worksite
|
We propose to conduct a randomized controlled trial of an Internet-enabled, automated self-management program. The study will be carried out through six local sites (offices) of a large employer. 3 sites will be intervention sites and 3 will be control sites.
Subjects enrolled from the intervention sites will receive a blood pressure meter and access to an Internet site where they can view their readings, read educational material regarding hypertension management and receive personalized tips and feedback.
Subjects enrolled from the control sites will have access to a blood pressure monitor located at their workplace but will only be provided with basic written information about hypertension at the start of the trial and will receive no feedback.
The trial will run for 6 months from the time of enrollment and the primary outcome measure will be a change in systolic blood pressure.
Ages Eligible for Study: | 30 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Massachusetts | |
Massachusetts General Hospital | |
Boston, Massachusetts, United States, 02114 |
Principal Investigator: | Joseph C. Kvedar, MD | Harvard University |
Responsible Party: | Massachusetts General Hospital ( Joseph Kvedar ) |
Study ID Numbers: | 2006-P-002440 |
Study First Received: | October 23, 2008 |
Last Updated: | November 4, 2008 |
ClinicalTrials.gov Identifier: | NCT00786162 |
Health Authority: | United States: Institutional Review Board |
Vascular Diseases Hypertension |
Cardiovascular Diseases |